|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 522.60 INR | -1.96% |
|
-1.27% | -6.02% |
| 03/02 | Ambuja Cements says Ajay Kapur superannuates as managing director effective January 31, 2026 | RE |
| 03/02 | Ambuja Cements says Ajay Kapur superannuated as managing director | RE |
| Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.01 | 7.45 | - | 5.16 | 3 | |||||
Return on Total Capital | 8.08 | 10.11 | - | 6.65 | 3.77 | |||||
Return On Equity % | 10.55 | 12.05 | - | 10.58 | 9 | |||||
Return on Common Equity | 10.1 | 11.56 | - | 9.78 | 8.78 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 66.51 | 65.28 | 54.05 | 59.57 | 55.88 | |||||
SG&A Margin | 32.97 | 31.13 | 30.89 | 29.42 | 29.18 | |||||
EBITDA Margin % | 20.15 | 21.22 | 11.67 | 18.85 | 16.39 | |||||
EBITA Margin % | 15.7 | 17.52 | 7.7 | 14.7 | 11.23 | |||||
EBIT Margin % | 15.67 | 17.46 | 7.65 | 14.56 | 10 | |||||
Income From Continuing Operations Margin % | 12.67 | 12.81 | 6.98 | 14.29 | 14.72 | |||||
Net Income Margin % | 9.65 | 9.6 | 6.2 | 10.79 | 11.89 | |||||
Net Avail. For Common Margin % | 9.65 | 9.6 | 6.2 | 10.79 | 11.89 | |||||
Normalized Net Income Margin | 7.5 | 8.15 | 4.85 | 6.98 | 7.47 | |||||
Levered Free Cash Flow Margin | 12 | 8.35 | - | 0.18 | -15.85 | |||||
Unlevered Free Cash Flow Margin | 12.46 | 8.67 | - | 0.69 | -15.49 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.68 | - | 0.57 | 0.48 | |||||
Fixed Assets Turnover | 1.69 | 1.86 | - | 1.61 | 1.18 | |||||
Receivables Turnover (Average Receivables) | 30.09 | 48 | - | 28.01 | 24.24 | |||||
Inventory Turnover (Average Inventory) | 4.38 | 4.58 | - | 3.23 | 3.94 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.38 | 1.52 | 1.67 | 2.05 | 1.42 | |||||
Quick Ratio | 1.03 | 1.11 | 1 | 1.45 | 0.81 | |||||
Operating Cash Flow to Current Liabilities | 0.52 | 0.47 | 0.05 | 0.47 | 0.16 | |||||
Days Sales Outstanding (Average Receivables) | 12.16 | 7.6 | - | 13.07 | 15.06 | |||||
Days Outstanding Inventory (Average Inventory) | 83.48 | 79.61 | - | 113.15 | 92.74 | |||||
Average Days Payable Outstanding | 107.19 | 83.94 | - | 87.28 | 64.88 | |||||
Cash Conversion Cycle (Average Days) | -11.54 | 3.28 | - | 38.93 | 42.92 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.62 | 1.47 | 1.35 | 1.37 | 1.24 | |||||
Total Debt / Total Capital | 1.59 | 1.45 | 1.33 | 1.36 | 1.22 | |||||
LT Debt/Equity | 1.46 | 1.25 | 1.16 | 1.02 | 0.74 | |||||
Long-Term Debt / Total Capital | 1.43 | 1.23 | 1.14 | 1 | 0.73 | |||||
Total Liabilities / Total Assets | 26.74 | 28.11 | 25.07 | 22.13 | 21.17 | |||||
EBIT / Interest Expense | 21.16 | 34.85 | 9.69 | 17.75 | 17.29 | |||||
EBITDA / Interest Expense | 27.55 | 42.78 | 15.04 | 23.67 | 29.39 | |||||
(EBITDA - Capex) / Interest Expense | 18 | 26.7 | 1.23 | 7.19 | -13.48 | |||||
Total Debt / EBITDA | 0.09 | 0.08 | 0.14 | 0.11 | 0.13 | |||||
Net Debt / EBITDA | -1.62 | -1.75 | -2.5 | -2.21 | -1.18 | |||||
Total Debt / (EBITDA - Capex) | 0.14 | 0.12 | 1.73 | 0.36 | -0.29 | |||||
Net Debt / (EBITDA - Capex) | -2.48 | -2.81 | -30.61 | -7.26 | 2.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -9.55 | 18.15 | - | 6.84 | 5.68 | |||||
Gross Profit, 1 Yr. Growth % | -5.92 | 15.96 | - | 17.76 | 2.13 | |||||
EBITDA, 1 Yr. Growth % | 7.65 | 24.46 | - | 72.6 | -8.12 | |||||
EBITA, 1 Yr. Growth % | 11.83 | 31.79 | - | 103.86 | -19.29 | |||||
EBIT, 1 Yr. Growth % | 11.76 | 31.71 | - | 103.39 | -27.36 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 11.63 | 19.45 | - | 118.55 | 8.95 | |||||
Net Income, 1 Yr. Growth % | 12.91 | 17.54 | - | 85.85 | 16.62 | |||||
Normalized Net Income, 1 Yr. Growth % | 8.07 | 28.43 | - | 53.93 | 13.22 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 12.89 | 17.55 | - | 78.31 | 1.86 | |||||
Accounts Receivable, 1 Yr. Growth % | -47.49 | 15.09 | - | 5.09 | 33.68 | |||||
Inventory, 1 Yr. Growth % | -21.37 | 66.08 | - | -22.89 | 17.72 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.59 | 10.43 | - | 30.99 | 53.57 | |||||
Total Assets, 1 Yr. Growth % | -1.15 | 13.81 | - | 26.25 | 24.33 | |||||
Tangible Book Value, 1 Yr. Growth % | -8.27 | 17.73 | - | 26.92 | 23.06 | |||||
Common Equity, 1 Yr. Growth % | -5.48 | 11.41 | - | 30.78 | 28.93 | |||||
Cash From Operations, 1 Yr. Growth % | 1.98 | 9.87 | - | 860.28 | -60.37 | |||||
Capital Expenditures, 1 Yr. Growth % | 3.97 | 34.64 | - | 32.4 | 93.8 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -6.86 | -17.77 | - | - | -604.98 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -7.62 | -17.85 | - | - | -530.07 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.1T | -65 | - | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.97 | 3.38 | - | - | 6.26 | |||||
Gross Profit, 2 Yr. CAGR % | -1.73 | 4.45 | - | - | 8.05 | |||||
EBITDA, 2 Yr. CAGR % | 10.99 | 15.75 | - | - | 25.93 | |||||
EBITA, 2 Yr. CAGR % | 15.99 | 21.4 | - | - | 28.27 | |||||
EBIT, 2 Yr. CAGR % | 15.96 | 21.33 | - | - | 21.49 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 2.23 | 15.47 | - | - | 54.25 | |||||
Net Income, 2 Yr. CAGR % | 4.23 | 15.2 | - | - | 47.15 | |||||
Normalized Net Income, 2 Yr. CAGR % | 30.91 | 17.82 | - | - | 31.93 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 4.24 | 15.2 | - | - | 34.69 | |||||
Accounts Receivable, 2 Yr. CAGR % | -34.42 | -22.26 | - | - | 17.37 | |||||
Inventory, 2 Yr. CAGR % | -25.34 | 14.28 | - | - | -4.72 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.26 | 7.47 | - | - | 41.93 | |||||
Total Assets, 2 Yr. CAGR % | 3.14 | 6.07 | - | - | 25.1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.07 | 3.92 | - | - | 25.44 | |||||
Common Equity, 2 Yr. CAGR % | 0.86 | 2.62 | - | - | 29.85 | |||||
Cash From Operations, 2 Yr. CAGR % | 68.43 | 5.85 | - | - | 95.08 | |||||
Capital Expenditures, 2 Yr. CAGR % | 25.09 | 18.31 | - | - | 60.19 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 330.32 | -12.48 | - | - | - | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 245.8 | -12.89 | - | - | - | |||||
Dividend Per Share, 2 Yr. CAGR % | 246.41 | 104.94 | - | - | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.3 | 3.61 | - | - | - | |||||
Gross Profit, 3 Yr. CAGR % | 1.64 | 3.85 | - | - | - | |||||
EBITDA, 3 Yr. CAGR % | 8.69 | 15.31 | - | - | - | |||||
EBITA, 3 Yr. CAGR % | 13.5 | 21.03 | - | - | - | |||||
EBIT, 3 Yr. CAGR % | 13.48 | 20.99 | - | - | - | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.9 | 7.68 | - | - | - | |||||
Net Income, 3 Yr. CAGR % | 15.98 | 8.49 | - | - | - | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.37 | 30.08 | - | - | - | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 15.97 | 8.5 | - | - | - | |||||
Accounts Receivable, 3 Yr. CAGR % | -15.55 | -20.89 | - | - | - | |||||
Inventory, 3 Yr. CAGR % | -12.47 | -2.54 | - | - | - | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.97 | 6.28 | - | - | - | |||||
Total Assets, 3 Yr. CAGR % | 3.8 | 6.58 | - | - | - | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.98 | 6.35 | - | - | - | |||||
Common Equity, 3 Yr. CAGR % | 3.26 | 4.26 | - | - | - | |||||
Cash From Operations, 3 Yr. CAGR % | 12.25 | 46.07 | - | - | - | |||||
Capital Expenditures, 3 Yr. CAGR % | 16.8 | 28.19 | - | - | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 14.92 | 147.86 | - | - | - | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 14.35 | 114.17 | - | - | - | |||||
Dividend Per Share, 3 Yr. CAGR % | 71 | 61.34 | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 21.05 | 7.55 | - | - | - | |||||
Gross Profit, 5 Yr. CAGR % | 20.64 | 7.07 | - | - | - | |||||
EBITDA, 5 Yr. CAGR % | 25.88 | 14.15 | - | - | - | |||||
EBITA, 5 Yr. CAGR % | 32.78 | 21.07 | - | - | - | |||||
EBIT, 5 Yr. CAGR % | 32.72 | 21.05 | - | - | - | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 30.92 | 20.94 | - | - | - | |||||
Net Income, 5 Yr. CAGR % | 23.97 | 20.27 | - | - | - | |||||
Normalized Net Income, 5 Yr. CAGR % | 22.98 | 19 | - | - | - | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 17.99 | 20.28 | - | - | - | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.08 | -6.91 | - | - | - | |||||
Inventory, 5 Yr. CAGR % | 12.92 | 4.82 | - | - | - | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.77 | 3.06 | - | - | - | |||||
Total Assets, 5 Yr. CAGR % | 22.96 | 6.61 | - | - | - | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.48 | 7.73 | - | - | - | |||||
Common Equity, 5 Yr. CAGR % | 17.25 | 5.05 | - | - | - | |||||
Cash From Operations, 5 Yr. CAGR % | 25.43 | 13.57 | - | - | - | |||||
Capital Expenditures, 5 Yr. CAGR % | 22.68 | 20.61 | - | - | - | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 42.9 | -5.01 | - | - | - | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 38.95 | -5.04 | - | - | - | |||||
Dividend Per Share, 5 Yr. CAGR % | 45.09 | 17.61 | - | - | - |
- Stock Market
- Equities
- AMBUJACEM Stock
- Financials Ambuja Cements
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















